[Plasma binding of drugs in chronic renal failure]
- PMID: 3774085
[Plasma binding of drugs in chronic renal failure]
Abstract
As in many pathological states, changes in the plasma protein binding of drugs are observed in uremia. Renal failure reduces the fraction of many acidic drugs bound to serum albumin. This decreased binding is due to many factors: variations of protein concentrations, structural changes of proteins, competitive displacers in plasma of chronic uremic patients. When the margin between pharmacological and toxic doses is narrow, drug monitoring by measurement of plasma free drug concentrations seems necessary to adjust the dosage regimen in uremic patients.
Similar articles
-
Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S38-41. doi: 10.1053/ajkd.2003.50082. Am J Kidney Dis. 2003. PMID: 12612950
-
Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.Clin Nephrol. 1976 Sep;6(3):388-93. Clin Nephrol. 1976. PMID: 136326
-
[Factors of variation in plasma protein binding of drugs in patients with chronic renal failure].Therapie. 1987 Oct-Dec;42(6):507-10. Therapie. 1987. PMID: 3441893 French. No abstract available.
-
[Characteristics of the pharmacokinetics of drugs in renal failure].Farmakol Toksikol. 1985 Sep-Oct;48(5):109-13. Farmakol Toksikol. 1985. PMID: 3908139 Review. Russian. No abstract available.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials